Table 1 Clinical and biochemical properties of the study population.
Parameters | T2DM without ACS, controls (n = 168) | T2DM with ACS, cases (n = 211) | p-value |
|---|---|---|---|
Male/female, N | 103/65 | 143/68 | 0.190 |
Age/(years) | 55 (48–63) | 63 (54–70) | < 0.001 |
BMI/(kg m-2) | 24.61 ± 2.5 | 24.01 ± 3.22 | 0.167 |
Smoking, N (%) | 38 (22.62%) | 63 (29.86%) | 0.120 |
Drinking, N (%) | 30 (17.86%) | 36 (17.06%) | 0.839 |
History of hypertension, N (%) | 77 (45.83%) | 142 (67.30%) | < 0.001 |
RBC/(× 1012 L−1) | 4.36 (3.99–4.81) | 4.26 (3.82–4.72) | 0.115 |
Hb/(g L−1) | 133.00 (119.00–144.25) | 132.00 (117.00–144.00) | 0.441 |
PLT/ (× 109 L−1) | 211.53 ± 66.99 | 211.12 ± 74.35 | 0.955 |
Glu/(mmol L−1) | 6.72 (5.52–8.38) | 7.17 (5.86–9.08) | 0.182 |
TG/(mmol L−1) | 1.831.16–2.80) | 1.72(1.17–2.16) | 0.122 |
TC/(mmol L−1) | 4.814.02–5.50) | 4.06(3.39–5.09) | < 0.001 |
HDL-C/(mmol L−1) | 0.97 (0.85–1.16) | 0.97(0.81–1.09) | 0.212 |
LDL-C/(mmol L−1) | 3.13 ± 0.87 | 2.72 ± 0.84 | < 0.001 |
UA/(mmol L−1) | 338.30 (275.70–392.70) | 356.10 (287.20–429.93) | 0.068 |
Urea/(mmol L−1) | 5.61 (4.49–7.48) | 6.20 (4.75–8.69) | 0.027 |
Cre/(mmol L−1) | 79.00 (65.00–94.00) | 86.10 (73.90–110.23) | < 0.001 |
CK/(U L−1) | 80.20 (60.05–120.58) | 99.60 (60.30–217.20) | 0.004 |
CK-Mb/(U L−1) | 12.00 (10.00–14.35) | 14.80 (11.50–23.20) | < 0.001 |
LDH/(U L−1) | 177.50 (153.55–208.00) | 219.00 (173.90–297.00) | < 0.001 |
Mb/(U L−1) | 33.25 (21.43–50.35) | 36.00 (22.90–77.40) | 0.042 |
NHR | 3.62 (2.69–5.13) | 5.00 (3.65–6.88) | < 0.001 |
